Drug
ravulizumab
Marketed as ULTOMIRIS.
Generic name
ravulizumab
Brand names
ULTOMIRIS
First FDA approval
2018-12-21
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761108 | ULTOMIRIS | 2018-12-21 | ALEXION PHARM |
Manufacturers
ALEXION PHARM
Frequently asked questions
When was ravulizumab FDA approved?
Earliest FDA approval on record: 2018-12-21.
What brand names are sold as ravulizumab?
ULTOMIRIS.
Sources
Appeal a ravulizumab denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com